The goal of Investigational Drug Services (IDS) is to ensure that clinical trials are carried out safely, effectively, and efficiently. IDS assures compliance with all federal, state, The Joint Commission, and Internal Review Board regulations concerning investigational study medication.
The service is covered by a member of IDS during business hours: Monday-Friday, 7:30 a.m. to 4 p.m.
After hour services for an investigational study are provided by the main pharmacy staff.
IDS can be contacted at 860-679-8707 (phone) and 860-679-1918 (fax).
Investigational Drug Service Policies
- I-001: Receipt, Storage and Records of Inpatient and Outpatient Investigational Drugs
- I-002: Temperature Storage of Investigational Drugs
- I-003: Inpatient Utilization of Investigational Drugs
- I-004: Inpatient/Outpatient Dispensing and Labeling of Investigational Drugs
- I-005: Compounding of Investigational Drugs
- I-006: Destruction and Returns of Investigational Drugs
- I-007: Charges for Investigational Drug Services
Investigational Service Policy Related Appendixes
- Appendix 1a: Room Temperature Monitor Form
- Appendix 1b: Fridge Temperature Monitor Form
- Appendix 1c: Freezer Temperature Monitor Form
- Appendix 2: Sample Script
- Appendix 3: Signature Log
- Appendix 4a: Base Billing Fees
- Appendix 4b: Pharmaceutical Sponsored Billing Fees
- Appendix 4c: Physician Sponsored Billing Fees
- Appendix 5: Drug Data Sheet
- Appendix 6: Site Training Log
- Appendix 7: Pharmacy Inspection Form
Services We Offer
- Randomization
- Drug accountability - Ordering, maintaining appropriate stock, checking for expired drug, inventory control
- Drug storage/temperature monitoring - Storage in area with limited access
- Refrigerator
- - 20 ºC freezer
- Drug destruction if unable to return to sponsor
- Oral medications
- Matched placebo if needed
- Intravenous medications
- Inpatient/outpatient
- Physician orders
- Billing for pharmacy services
- Maintenance of discontinued study files
- Staff education and assistance
- Assistance with investigational new drugs